In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

The steady approval of new biosimilars in recent years provides additional safe, effective, and cost-effective options for ...

Black and Latinx individuals tend to experience more severe and persistent symptoms. Here, we highlight some of their stories ...

The Beryl Institute, a global community of healthcare professionals and advocates dedicated to improving the human experience in healthcare, has announced the recipients of its 2025 Patient Experience ...

Localized supply chains are crucial for mitigating geopolitical risks and ensuring operational continuity in the biopharmaceutical sector. Regulatory harmonization enhances access to medicines, ...

Envista Holdings Corporation ( NVST) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT ...

Everest Medicines (HKEX:1952.HK) today announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Biosciences (formally known as I-Mab, and is a ...

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it ...

A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, ...